Myomo Inc (MYO) USD0.0001

Sell:$4.84Buy:$4.90$0.04 (0.83%)

Prices delayed by at least 15 minutes
Sell:$4.84
Buy:$4.90
Change:$0.04 (0.83%)
Prices delayed by at least 15 minutes
Sell:$4.84
Buy:$4.90
Change:$0.04 (0.83%)
Prices delayed by at least 15 minutes

Company Information

About this company

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Key people

Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
David A. Henry
Chief Financial Officer
Harry Kovelman
Chief Medical Officer
Micah J. Mitchell
Chief Commercial Officer
Thomas F. Kirk
Lead Independent Director
Thomas A. Crowley
Independent Director
Heather C. Getz
Independent Director
Yitzchak Jacobovitz
Independent Director
Amy Knapp
Independent Director
Click to see more

Key facts

  • EPIC
    MYO
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US62857J2015
  • Market cap
    $165.37m
  • Employees
    184
  • Shares in issue
    34.38m
  • Exchange
    Nyse American LLC
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.